AR005549A1 - Derivados de la 1-pirazol-3-iletil-4-indol-3-ilpiperidina, un procedimiento para prepararlos, medicamentos y preparaciones farmaceuticas que los contienen,un procedimiento para preparar las preparaciones farmaceuticas y empleo de los mismos para la preparacion de medicamentos. - Google Patents
Derivados de la 1-pirazol-3-iletil-4-indol-3-ilpiperidina, un procedimiento para prepararlos, medicamentos y preparaciones farmaceuticas que los contienen,un procedimiento para preparar las preparaciones farmaceuticas y empleo de los mismos para la preparacion de medicamentos.Info
- Publication number
- AR005549A1 AR005549A1 ARP970100297A ARP970100297A AR005549A1 AR 005549 A1 AR005549 A1 AR 005549A1 AR P970100297 A ARP970100297 A AR P970100297A AR P970100297 A ARP970100297 A AR P970100297A AR 005549 A1 AR005549 A1 AR 005549A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparations
- preparing
- procedure
- pharmaceutical preparations
- indol
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title 2
- 239000003814 drug Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 210000003169 central nervous system Anatomy 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052731 fluorine Inorganic materials 0.000 abstract 2
- YLRRJIXSMHWUEC-UHFFFAOYSA-N 3-[1-[1-(1h-pyrazol-5-yl)ethyl]piperidin-4-yl]-1h-indole Chemical class C1CC(C=2C3=CC=CC=C3NC=2)CCN1C(C)C1=CC=NN1 YLRRJIXSMHWUEC-UHFFFAOYSA-N 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- MFOBKQAGVZYMON-UHFFFAOYSA-N cyanoformohydrazide Chemical compound NNC(=O)C#N MFOBKQAGVZYMON-UHFFFAOYSA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 230000007257 malfunction Effects 0.000 abstract 1
- -1 monosubstituted phenyl Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19602505A DE19602505A1 (de) | 1996-01-25 | 1996-01-25 | 1-(Pyrazol-4-Indol-3-yl)-Piperidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR005549A1 true AR005549A1 (es) | 1999-06-23 |
Family
ID=7783568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970100297A AR005549A1 (es) | 1996-01-25 | 1997-01-24 | Derivados de la 1-pirazol-3-iletil-4-indol-3-ilpiperidina, un procedimiento para prepararlos, medicamentos y preparaciones farmaceuticas que los contienen,un procedimiento para preparar las preparaciones farmaceuticas y empleo de los mismos para la preparacion de medicamentos. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0879234A1 (cs) |
| JP (1) | JP2000503972A (cs) |
| KR (1) | KR19990081970A (cs) |
| CN (1) | CN1209807A (cs) |
| AR (1) | AR005549A1 (cs) |
| AU (1) | AU715785B2 (cs) |
| BR (1) | BR9707467A (cs) |
| CA (1) | CA2244136A1 (cs) |
| CZ (1) | CZ231898A3 (cs) |
| DE (1) | DE19602505A1 (cs) |
| HU (1) | HUP9900980A2 (cs) |
| NO (1) | NO983439L (cs) |
| PL (1) | PL328228A1 (cs) |
| SK (1) | SK99298A3 (cs) |
| WO (1) | WO1997027186A1 (cs) |
| ZA (1) | ZA97572B (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001021614A1 (en) * | 1999-09-09 | 2001-03-29 | H. Lundbeck A/S | 5-aminoalkyl and 5-aminocarbonyl substituted indoles |
| HK1045991B (en) | 1999-11-10 | 2004-12-10 | Takeda Pharmaceutical Company Limited | 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| US7589202B2 (en) | 2000-08-14 | 2009-09-15 | Ortho Mcneil Pharmaceutical, Inc. | Substituted pyrazoles |
| US7332494B2 (en) | 2000-08-14 | 2008-02-19 | Janssen Pharmaceutica, N.V. | Method for treating allergies using substituted pyrazoles |
| WO2003042208A1 (en) * | 2001-11-14 | 2003-05-22 | Merck Patent Gmbh | Pyrazole derivatives as psychopharmaceuticals |
| ATE477255T1 (de) | 2005-10-11 | 2010-08-15 | Hoffmann La Roche | Imidazobenzdiazepinderivate |
| AU2006306497A1 (en) * | 2005-10-24 | 2007-05-03 | Janssen Pharmaceutica, N.V. | 3-piperidin-4-yl-indole ORL-1 receptor modulators |
| TWI548630B (zh) | 2011-04-06 | 2016-09-11 | Ｌｇ生命科學有限公司 | １－（３－氰基－１－異丙基－吲哚－５－基）吡唑－４－羧酸結晶型及其製造方法 |
| WO2022098057A1 (ko) * | 2020-11-04 | 2022-05-12 | 주식회사 엘지화학 | 1-(3-시아노-1-아이소프로필-인돌-5-일)피라졸-4-카르복실산의 결정성 입자의 제조방법 및 이를 포함하는 약학적 조성물 |
| WO2025021120A1 (zh) * | 2023-07-24 | 2025-01-30 | 上海翊石医药科技有限公司 | 一类5-ht2a受体激动剂及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2060816C3 (de) * | 1970-12-10 | 1980-09-04 | Merck Patent Gmbh, 6100 Darmstadt | 4-Phenylpiperidinderivate Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen enthaltend diese Verbindungen |
| DE2258033A1 (de) * | 1972-11-27 | 1974-05-30 | Merck Patent Gmbh | Verfahren zur herstellung von pyrazolderivaten |
| GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
| US5045550A (en) * | 1990-09-20 | 1991-09-03 | Warner-Lambert Co. | Substituted tetrahydropyridines as central nervous system agents |
| US5521196A (en) * | 1994-10-05 | 1996-05-28 | Eli Lilly And Company | 5-HT1F agonists for the treatment of migraine |
-
1996
- 1996-01-25 DE DE19602505A patent/DE19602505A1/de not_active Withdrawn
-
1997
- 1997-01-17 PL PL97328228A patent/PL328228A1/xx unknown
- 1997-01-17 CZ CZ982318A patent/CZ231898A3/cs unknown
- 1997-01-17 SK SK992-98A patent/SK99298A3/sk unknown
- 1997-01-17 CA CA002244136A patent/CA2244136A1/en not_active Abandoned
- 1997-01-17 JP JP9526493A patent/JP2000503972A/ja active Pending
- 1997-01-17 HU HU9900980A patent/HUP9900980A2/hu unknown
- 1997-01-17 WO PCT/EP1997/000187 patent/WO1997027186A1/de not_active Application Discontinuation
- 1997-01-17 EP EP97901049A patent/EP0879234A1/de not_active Withdrawn
- 1997-01-17 CN CN97191852A patent/CN1209807A/zh active Pending
- 1997-01-17 AU AU14432/97A patent/AU715785B2/en not_active Ceased
- 1997-01-17 BR BR9707467A patent/BR9707467A/pt unknown
- 1997-01-17 KR KR1019980705688A patent/KR19990081970A/ko not_active Withdrawn
- 1997-01-23 ZA ZA9700572A patent/ZA97572B/xx unknown
- 1997-01-24 AR ARP970100297A patent/AR005549A1/es unknown
-
1998
- 1998-07-24 NO NO983439A patent/NO983439L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1209807A (zh) | 1999-03-03 |
| NO983439L (no) | 1998-09-25 |
| DE19602505A1 (de) | 1997-07-31 |
| EP0879234A1 (de) | 1998-11-25 |
| NO983439D0 (no) | 1998-07-24 |
| KR19990081970A (ko) | 1999-11-15 |
| JP2000503972A (ja) | 2000-04-04 |
| AU1443297A (en) | 1997-08-20 |
| ZA97572B (en) | 1997-08-04 |
| BR9707467A (pt) | 1999-07-20 |
| PL328228A1 (en) | 1999-01-18 |
| WO1997027186A1 (de) | 1997-07-31 |
| AU715785B2 (en) | 2000-02-10 |
| SK99298A3 (en) | 1999-01-11 |
| CZ231898A3 (cs) | 1998-10-14 |
| CA2244136A1 (en) | 1997-07-31 |
| HUP9900980A2 (hu) | 1999-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0447285T3 (da) | Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem | |
| DK0705254T3 (da) | Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer | |
| ATE185792T1 (de) | Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen | |
| AR017164A1 (es) | Derivados de la benzamidina, un procedimiento para prepararlos, el empleo de los mismos para preparar un medicamento, los medicamentos y laspreparaciones farmaceuticas que contienen estos derivados de la benzamidina, y un procedimiento para obtener estas preparaciones farmaceuticas. | |
| AR008377A1 (es) | Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto | |
| AR050261A2 (es) | Aminoacidos con afinidad por la proteina alfa-2-delta y composiciones farmaceuticas que los contienen y su uso para preparar un medicamento | |
| PA8452201A1 (es) | Derivados de 9-desoxo-9a-aza-9a -homoeritromicina a c-4"sustituidos. | |
| DE69624437D1 (de) | 4,6-diarylpyrimidin-derivate und deren salze | |
| ES2108717T3 (es) | Derivados de la tetrahidropirrolo(1,2-a)pirazina-4-espiro-3'-pirrolidina, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. | |
| ES2122637T3 (es) | Derivados de tiazolidina, su preparacion y los medicamentos que les contienen. | |
| AR005549A1 (es) | Derivados de la 1-pirazol-3-iletil-4-indol-3-ilpiperidina, un procedimiento para prepararlos, medicamentos y preparaciones farmaceuticas que los contienen,un procedimiento para preparar las preparaciones farmaceuticas y empleo de los mismos para la preparacion de medicamentos. | |
| AR046874A1 (es) | Nuevos metodos | |
| ES2103440T3 (es) | Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| ES2063117T3 (es) | Derivados del tieno(2,3-d)acepina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| AR017146A1 (es) | Compuestos de 1-(fenil-sustituido)-5-(4-metilsulfonilfenil)pirazol; procedimiento para prepararlos, las composiciones farmaceuticas que los contienen,los agentes inhibidores de la cox-ii que los contienen y el uso de dichos compuestos para la fabricacion de medicamentos. | |
| AR008494A1 (es) | Empleo de las pirazolinonas para el tratamiento de los trastornos de la potencia, preparaciones farmaceuticas que las contienen, empleo de estaspreparaciones farmaceuticas para el tratamiento y/o la terapia de los trastornos de la potencia y un procedimiento para prepararlas | |
| ES2038216T3 (es) | Procedimiento para la preparacion de 5-(3-alquil-5-t-butil-4-hidroxi-fenil)-2-amino-6h-1,3,4-tiadazinas y su empleo. | |
| ES2182090T3 (es) | Nuevos derivados de pirrol. | |
| ES2086528T3 (es) | Nuevos compuestos biciclicos sustituidos con amino. | |
| ES2094638T3 (es) | N-acilpirrolidinas y medicamentos para el tratamiento o la prevencion de los desordenes relacionados con la colecistoquinina y la gastrina. | |
| ES2122221T3 (es) | Compuestos terapeuticos adecuados para el tratamiento de enfermedades conectadas con la deficiencia de glutation, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| AR004680A1 (es) | Derivados de la alquenil-benzoilguanidina, procedimiento para prepararlos y preparaciones farmaceuticas que los contienen. | |
| MX9203068A (es) | Compuestos activirales oralmente activos. | |
| MX9704035A (es) | 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos. | |
| ES531318A0 (es) | Procedimiento para la obtencion de derivados quinolinicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |